Aug 8 (Reuters) - Valeant Pharmaceuticals International Inc (NYSE:VRX) VRX.TO :
* Valeant pharmaceuticals announces licensing agreement with Norgine B.V. For NER1006 in U.S. and Canada
* Norgine will manufacture and supply NER1006 for Valeant
* Valeant Pharmaceuticals announces licensing agreement with Norgine B.V. for NER1006 in U.S. and Canada
* Financial terms of agreement have not been disclosed. Source text for Eikon: ID:nCNWxvXY5a Further company coverage: VRX.TO